Your body produces two hormones called GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) that regulate blood sugar, appetite, and fat metabolism
This mechanism allows individuals to experience fat reduction without the muscle growth or insulin resistance risks often associated with full-spectrum growth hormone therapies
Side effects vary from person to person and depend on many factors, including dosage, treatment duration, overall health, and individual sensitivity
Our experienced team, led by Dr
Dose-response and time-course designs are common in this compound class to characterize concentration-dependent effects, and researchers often pair AHK-Cu with structurally related copper peptides as comparative controls within the same experimental design, including common comparative peptides like TB-500 and BPC-157